ONDS — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-13

• Sales and marketing expenses (“S&M”) increased $18.6 million, or 822%, to $20.9 million for the three months ended June 30, 2026, from $2.3 million for the three months ended June 30, 2025. This increase is primarily due to an increase of $14.5 million related to S&M attributable to companies acquir…

• Research and development expenses (“R&D”) increased $26.8 million, or 631%, to $31.0 million for the three months ended June 30, 2026, from $4.2 million for the three months ended June 30, 2025. This increase is primarily due to an increase of $21.1 million related to R&D attributable to companies a…

• The Company recorded $19.2 million of expense for the three months ended June 30, 2026, related to the change in fair value of contingent consideration based on changes in the significant unobservable inputs used in the valuation of the contingent consideration liabilities, which may include project…

• Total other income, net increased $45.7 million, to $44.2 million for the three months ended June 30, 2026, from total other expense, net of $1.5 million for the three months ended June 30, 2025. Total other income, net increased primarily as a result of an increase of approximately $27.6 million in…

• The Company recorded an income tax benefit of $29.1 million for the three months ended June 30, 2026, and an income tax provision of $0 for the three months ended June 30, 2025. The 2026 income tax benefit is related to current-year tax losses. The benefit was recognized because the associated defer…

Text removed vs the prior filing · source: 10-Q · 2026-05-15

• Sales and marketing expenses (“S&M”) increased $8.1 million, or 332%, to $10.5 million for the three months ended March 31, 2026, from $2.4 million for the three months ended March 31, 2025. This increase is primarily due to (i) an increase of $5.4 million related to S&M attributable to companies ac…

• Research and development expenses (“R&D”) increased $10.0 million, or 291%, to $13.5 million for the three months ended March 31, 2026, from $3.5 million for the three months ended March 31, 2025, of which $7.8 million related to companies acquired since March 31, 2025. Other increases in R&D includ…

• Total other income, net increased $408 million to $404.2 million for the three months ended March 31, 2026, from total other expense, net of $3.8 million for the three months ended March 31, 2025. Total other income, net increased primarily as a result of the net gain of $389.5 million related to th…

• The Company recorded an income tax provision of $245 thousand for the three months ended March 31, 2026, and an income tax provision of $0 for the three months ended March 31, 2025. The 2026 income tax provision is attributable to earnings in foreign jurisdictions.

• Net income increased $375.4 million to $361.3 million for the three months ended March 31, 2026, from a net loss of $14.1 million for the three months ended March 31, 2025. For the three months ended March 31, 2026, the Company attributed $1.7 million of net loss to noncontrolling interests (“NCI”),…

Text added vs the prior filing · source: 10-Q · 2026-08-13

• We are a smaller reporting company as defined by Rule 229.10(f)(1) and are not required to provide information under this item. Although we are not required to provide the quantitative and qualitative disclosures about market risk required by this Item, we are exposed to certain market risks in the …

• Except for the market risk associated with our warrant liabilities described above, there have been no material changes to our exposure to market risk for the six months ended June 30, 2026 from those previously disclosed under “Quantitative and Qualitative Disclosures About Market Risk” contained i…

Text removed vs the prior filing · source: 10-Q · 2026-05-15

• We are a smaller reporting company as defined by Rule 229.10(f)(1) and are not required to provide information under this item. Although we are not required to provide the quantitative and qualitative disclosures about market risk required by this Item, there have been no material changes to our exp…

Text added vs the prior filing · source: 10-Q · 2026-08-13

• During the quarter ended June 30, 2026, the Company continued to integrate recently acquired businesses into its control environment. As permitted by SEC guidance, companies are permitted to exclude acquisitions from their final assessment of internal control over financial reporting for a period no…

• Except as described above, there were no changes in the Company's internal control over financial reporting during the quarter ended June 30, 2026 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Text removed vs the prior filing · source: 10-Q · 2026-05-15

• There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the quarter ended March 31, 2026 that materially affected, or are reasonably likely to materially affect, our internal cont…